DALLAS, March 25, 2015 /PRNewswire/ --
Sandlerresearch.org adds "Global Epinephrine Autoinjector Market 2015-2019" a news report added. The Global Epinephrine Autoinjector Market is expected to grow at a CAGR of 13.12% from 2015-2019.
The latest "Global Epinephrine Autoinjector Market 2015-2019" report draws attention towards the availability of improved injecting devices. Autoinjectors offer audio instructions for proper administration of the medication and are easily available in the market. It also addresses many issues like high cost, lack of reusability and needle phobia.
The prevalence of allergies to food items, food additives, latex, as well as associated anaphylaxis has been increasing worldwide. On average, 35 percent of the population is diagnosed with an allergy, annually. Initially, this trend was only seen in areas like the UK, Europe and the US, but it is now common in all industrially developed countries.
Epinephrine works immediately and helps reduce the symptoms of a life-threatening allergy, which is expected to boost the market growth during the forecast period.
Continuous product modifications and several advances in technology for the development of innovative epinephrine injectors are expected to drive the market in the positive direction through the projected period.
Epinephrine, commonly known as adrenaline, is a hormone secreted by the medulla of the adrenal gland and circulated through the bloodstream. It acts as a neurotransmitter that responds to brain signals. These signals trigger responses such as threat, excitement, danger, emotion, and stress, which stimulate the adrenal gland to secrete epinephrine in response to the changes in the body. Adrenaline prepares the body to fight against anaphylactic shock that occurs due to allergic reactions, cardiac arrest, asthma, and superficial bleeding. Chemically synthesized epinephrine is usually administered to patients suffering from the above symptoms because it stimulates the heartbeat, increases blood pressure, relaxes involuntary muscles, and constricts small blood vessels. Epinephrine is also used with local anesthetic agents such as bupivacaine and lidocaine to enhance the effect of anesthesia. It is available in injection form as well as aerosol form for inhalation.
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.
This report covers the present scenario and the growth prospects of the Global Epinephrine Auto-injector market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various epinephrine auto-injectors that are available in the market.
Order a Copy of Report at http://www.sandlerresearch.org/purchase?rname=34443.
The report, Global Epinephrine Auto-injector Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Other Reports on Therapeutics Market:
Global Joint Reconstruction Market 2015-2019 (http://www.sandlerresearch.org/global-joint-reconstruction-market-2015-2019.html): The analysts forecast the Global Joint Reconstruction market to grow at a CAGR of 5.55% over the period 2014-2019. The Global Joint Reconstruction market can be segmented into Knee Implants, Hip Implants, and Trauma & Extremities.
The report Global Joint Reconstruction Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Joint Reconstruction market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Vendors: DePuy Synthes (a Johnson & Johnson Company), Smith & Nephew, Stryker, Zimmer Holdings
Other Prominent Vendors: Aesculap Implant Systems (a B. Braun company), Arthrex, ConforMIS, Corenetec, Corin, Elite Surgical, EUROS FRANCE, Evolutis, FH ORTHOPEDICS, Integra LifeSciences, Lima Corporate, Medacta, Ortosintese, Peter Brehm, Shanghai MicroPort Orthopedics, Surgival, Synergie Ingénierie Médicale, Tornier.
Global Hip Implant Market 2015-2019 (http://www.sandlerresearch.org/global-hip-implant-market-2015-2019.html): The analysts forecast the Global Hip Implant market to grow at a CAGR of 2.98% over the period 2014-2019.
The report covers the present scenario and the growth prospects of the Global Hip Implant market for the period 2015-2019. Based on surgical procedure, the market can be segmented into three: Primary Hip Replacement, and Partial Hip and Revision Hip Replacement.
The report, Global Hip Implant Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Hip Implant market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
SandlerResearch.org is your go-to source for all market research needs. Our database includes thousands of market research reports from over multiple leading global publishers & in-depth market research studies of over several micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Connect with Us:
G+ / Google Plus: https://plus.google.com/106598308303011242341/posts
SOURCE Sandler Research